The Brief keeps Texas voters and political observers up to speed on the most essential coverage of their elected officials, the policies that shape their daily lives and the future of our great state.
As a writer for Forbes Home since 2021, Emily specializes in writing about home warranties, solar installations, car transportation and moving companies. With a background in journalism and experience ...
AT&T customers could be eligible to receive thousands of dollars from the telecommunications company as part of a $177 million class action settlement. The settlement stems from a lawsuit that alleges ...
The selloff in Array Digital Infrastructure's fixed-income securities post-UScellular sale is overdone, creating an attractive entry point. AD's 5.50% Senior Notes now yield 8.05% and trade at a 31.6% ...
Gilead Sciences has become the latest pharma to strengthen its in vivo cell therapy credentials this year, paying $350 million for CAR-T developer Interius BioTherapeutics. Integrating Interius into ...
Millions of AT&T customers can now file claims in a $177 million legal settlement related to two data breaches, which could provide up to $7,500 in compensation per person. Multiple lawsuits were ...
Could you get part of the $177 million settlement that AT&T will start paying customers soon? The funds are a settlement in a class action lawsuit that alleged customer data was breached multiple ...
After suffering two significant data breaches in recent years, AT&T has agreed to pay $177 million to customers affected by the incidents. Some individuals could receive as much as $5,000 as part of ...
BELLEVUE, Wash.--(BUSINESS WIRE)--T-Mobile US, Inc. (NASDAQ: TMUS) (the “Company”) today announced, together with T-Mobile USA, Inc., its wholly-owned subsidiary (“T-Mobile USA”), the expiration and ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Chicago-based wireless company ...
T-Mobile is reportedly offering a new loyalty discount of $830 on device trade-ins for select existing customers. To be eligible, customers must not have any active equipment installment plans. The ...
AbbVie is making a full strength play for the in vivo CAR-T market, snapping up Capstan Therapeutics for $2.1 billion to add an early-phase autoimmune drug candidate to its pipeline. Capstan is part ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback